Prof. Nassiri as an OCM in our Conference

HIV Community & Planning

                        

          Scientific Federation proudly invites all the participants from all over the world to attend 2nd International Conference & Expo on HIV & AIDS during Sep 17-18, 2018 in Toronto, Canada.

          Prof. Nassiri is an OCM in our Conference and he is a former Associate Dean of Global Health at the Michigan State University (MSU).  He also served as MSU director of Institute of International Health.  He is currently a faculty member of the departments of Pharmacology and Toxicology, and, Family and Community Medicine, and, lecturer in Global Health, Infectious Diseases, and Tropical Medicine.  He currently works on international public health issues relating to chronic diseases and has expertise in global health. He has made contributions in various fields of medical sciences including clinical investigation and health education. On the basis of his extensive experience and expertise in chronic infectious diseases including HIV/AIDS, TB as well as antimicrobial resistance and human gut microbiome, he developed clinical research programs in Brazil, South Africa, Haiti, Dominican Republic and Mexico. He had served as editorial board member for the Journal of HIV and AIDS Review.  He is currently an editorial board member for AIDS Patient Care and STDs, and International Journal of Global Health.  Prof. Nassiri has delivered seminar presentations on Tropical Medicine, HIV/AIDS, TB, Global Health and public health interventions in numerous national and international conferences and workshops. He is internationally recognized for his work in the areas of building effective international partnerships particularly in global health, community health, clinical care capacity building, and technical assistance mechanism. He has developed academic and research partnership programs with Federal University of Para Institute of Tropical Medicine in Belem, Brazil.

          AIDS remains a public health and social challenge threatening the global population.  There are approximately 36.5 million people currently living with HIV and tens of millions of people have died of AIDS-related complications since the beginning of the epidemic. The greatest prevalence and incidence remains in Eastern and southern Africa with 19 million (52%) affected.  While new cases have been reported in all regions of the world, approximately two-thirds are in sub-Saharan Africa, with 46% of new cases in Eastern and Southern Africa.  In the endemic regions outside the western countries, many people living with HIV or at risk for HIV do not have access to prevention, care, and treatment.  HIV impacts households, communities, and the development and economic growth of nations.

          The number of HIV-positive patients receiving treatment has increased to more than 18 million in 2016.  However, significant gaps exist.  While studies show declines in new infections among adults observed earlier in the epidemic, the incidence is now rising particularly in China and India.  HIV epidemic has led to a resurgence of tuberculosis (TB), particularly in Africa.  TB is a leading cause of death for people with HIV worldwide.  In 2015, approximately 11% of new TB cases occurred in people living with HIV.  Interestingly, between 2004 and 2014 TB deaths in people living with HIV declined by 32%, largely due to the scale-up of joint HIV/TB services (The Global HIV/AIDS Epidemic, Kaiser Family Foundation.  January 2017). 

          From our experience of HIV preventive work in the Dominican Republic, effective prevention strategies include behavior change programs, condom use, HIV testing, blood supply safety, harm reduction efforts for injecting drug users, and male circumcision (WHO and CDC recommendations). Additionally, recent research has shown that providing HIV treatment to people with HIV significantly reduces the risk of transmission to their HIV-negative partners. Pre-exposure antiretroviral prophylaxis (PrEP) has also been shown to be an effective HIV prevention strategy in individuals at high risk for HIV infection.  In 2015, the WHO recommended PrEP as a form of prevention for high-risk individuals in combination with other prevention methods.  Additionally, in 2016, the U.N. Political Declaration on HIV/AIDS stated PrEP research and development should be accelerated.  Numerous studies suggest that prevention should be based upon “evidenced-based knowledge of epidemic” directed to tailor the prevention and control measures to the local context and epidemiology, and using a combination of sustainable strategies.  However, access to prevention remains limited especially in resource-limited counties, and there have been renewed calls for the strengthening of prevention efforts. 

          In the United States, new HIV infections are becoming rare.  When they do occur, every person, regardless of age, gender, race/ethnicity, sexual orientation, gender identity, or socio-economic circumstance, will have access to quality, life-extending care, free from stigma and discrimination.  The goals of the US national HIV/AIDS prevention and control strategies are to reduce new HIV infections, to allow increased access to care and improved outcomes among People Living with HIV, to reduce HIV-related disparities and health inequities among the minority and migrant populations, and to achieve a more coordinated HIV national response (National HIV/AIDS Strategy, the White House, July 2012). 

          The Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia has dramatically impacted the regional response to the epidemic. The monitoring process of the Declaration has provided valuable insight on the progress of HIV prevention and control by countries and where improvements in national programs must be made to reduce the number of new infections and improve the quality of life for people living with HIV.  

          HIV-AIDS-2018 will provide the excellent opportunities for the researchers, scientists, professors, delegates and students from all over the world exchange information on HIV-AIDS which contains plenary sessions, keynote speeches, poster, and oral presentations on HIV-AIDS On Emerging area on Immunology, Microbiology, Infection&Imunnity, Public Health, Infectious Diseases, Virology, Pathology, Psychology, Biochemistry, Epidemiology, Gynecology, Global Health, and Population Health.

To Know More about Hiv-Aids-2018: Click Here